<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peripheral blood samples from 48 untreated and 20 treated patients with disease entities that directly or indirectly affect hematopoiesis [dys-myelopoietic syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DMS</z:e>), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) or in transformation (RAEBIT), <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:mp ids='MP_0009440'>myeloma</z:mp>, acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>), and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> with uninvolved bone marrow] were measured with the Technicon H-6000 automated hematology analyzer; this instrument provides a differential count on 10(4) white blood cells (WBC) effected by means of flow cytochemistry (peroxidase content) and volume (light scatter) discrimination </plain></SENT>
<SENT sid="1" pm="."><plain>Cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DMS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> showed statistically significantly lower WBC counts than <z:mpath ids='MPATH_458'>normal</z:mpath>, whereas cases with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> showed significantly higher values </plain></SENT>
<SENT sid="2" pm="."><plain>No disease entity demonstrated changes in mean peroxidase activity (MPA) that were significantly different from <z:mpath ids='MPATH_458'>normal</z:mpath>, although <z:hpo ids='HP_0000001'>all</z:hpo> disease entities, including cases with <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, showed significantly higher (two to severalfold) proportions of cells with high peroxidase (HPX) content, probably as a reflection of a disturbance of <z:mpath ids='MPATH_458'>normal</z:mpath> hemopoiesis with the emergence of younger granulocytic forms </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cases with paraleukemia (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DMS</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, and RAEBIT) showed significantly higher values of large unstained cells (LUC), whereas cases with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> showed significantly lower LUC values </plain></SENT>
<SENT sid="4" pm="."><plain>There were no statistically significant differences for any parameter (WBC counts, MPA, HPX, or LUC) among the paraleukemia subtypes </plain></SENT>
<SENT sid="5" pm="."><plain>However, based on the displayed trends, a case presenting with dyserythropoiesis, relatively low WBC counts, abnormal HPX values, and LUC below 10% should be suspected for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, whereas the presence of greater than 10% LUC and almost <z:mpath ids='MPATH_458'>normal</z:mpath> or even slightly elevated WBC counts should suggest a more accelerated phase of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Unless complicated by a leukemic phase, cases of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> or <z:mp ids='MP_0009440'>myeloma</z:mp> did not display changes in any of the parameters analyzed by the H-6000 </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> had no overt changes other than a trend to lower WBC counts with occasionally higher or lower absolute lymphocyte counts than <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>The peripheral blood of patients with <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> displayed a slight increase in HPX, suggesting an indirect effect on hemopoiesis since careful workup failed to demonstrate bone marrow involvement </plain></SENT>
<SENT sid="9" pm="."><plain>Our data demonstrates that an H-6000 analysis has a role in the evaluation and follow-up of <z:hpo ids='HP_0000001'>all</z:hpo> these entities particularly to document leukemic transformation of either <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:mp ids='MP_0009440'>myeloma</z:mp>, or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> </plain></SENT>
</text></document>